乌鸦传媒

Remission of coexisting conditions was also maintained, long-term data show

Patients taking the GLP-1 drug also had greater improvement in physical function

New guidance replaces earlier rec of a 1-week and 1-day hold of injectable and oral GLP-1 agents

However, 24 weeks of the GLP-1 had no impact on eGFR

Researchers observed dose-response relationship for increasing BMI and long COVID risk

GLP-1 receptor agonists may have better protective benefits versus metformin, insulin

Health news and commentary gathered by 乌鸦传媒 staff

But Japanese study suggests losses need to be substantial

GLP-1 treatment was tied to lower risks of suicidal ideation, attempts vs lifestyle interventions

Including lipids did not prove superior to non-laboratory-based criteria alone, study finds

Risk of new diabetes diagnosis was higher compared with non-COVID respiratory infections

I anticipate benefits outweighing potential risks in only a select few situations

Bowel preparation protocols appeared protective in small study

Other than staying on drug, there's no evidence-based strategy to maintain weight loss